Advertisement

Topics

Alkermes plc Reports Second Quarter 2016 Financial Results

07:01 EDT 28 Jul 2016 | Alkermes plc

— Second Quarter Revenues Increase 29% Year-Over-Year to $195.2 Million; GAAP Loss per Share of $0.31 and Non-GAAP Loss per Share of $0.01 — — Company Improves Financial Expectations for 2016 Driven by Strong VIVITROL® Performance — — ARISTADA® Revenues Grow as Launch Progresses — DUBLIN--(BUSINESS WIRE)--Jul. 28, 2016-- Alkermes plc (NASDAQ: ALKS) today reported financial results for the second quarter of 2016. “Our second quarter results demonstrate the power of our business model to efficiently capture operating leverage as our topline grows. These results reflect the gro...

Original Article: Alkermes plc Reports Second Quarter 2016 Financial Results

NEXT ARTICLE

More From BioPortfolio on "Alkermes plc Reports Second Quarter 2016 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement